Bal Pharma Share Price

    NSE
    101.68
    +0.18 (0.00%)
    BALPHARMA • 01 Jul, 2025 | 12:20 PM
    BUY

    1Y Annualised Return

    -16.33%

    3Y Annualised Return

    1.84%

    5Y Annualised Return

    18.75%

    The current prices are delayed, login or Open Demat Account for live prices.

    Bal Pharma Stock Performance

    1W Return2.60
    1Y Return-15.30
    Today's Low101.13
    Prev. Close101.50
    Mkt Cap (Cr.)161.60
    1M Return4.04
    3Y Return6.16
    52-Week High157.98
    Open103.00
    PE Ratio20.72
    6M Return-19.58
    Today's High103.29
    52-Week Low78.06
    Face Value10

    Bal Pharma Company background

    Founded in: 1987
    Managing director: Shailesh Siroya
    Bal Pharma Ltd (BPL), a member of the Mcro Laboratories Group, was incorporated as a private limited company in May 87. In Mar.90, BPL took over a pharmaceutical products manufacturing unit located in Bangalore through the Karnataka State Finance Corporation for a consideration of Rs 25.18 lac following which, BPL commenced manufacturing formulations.BPL manufactures and markets pharmaceutical formulations paracetamol, aluminium hydroxide, povidone iodine, alprazolam, gliclazide, griseofulvin, lactobacillus, rifampicin, piroxicam amoxycillin, etc. The company promotes its products through the common sales force of the group but proposes to induct its own soon. It came out with a public issue in Feb.95 for manufacture of bulk drugs and expansion of pharmaceutical formulations.During 199798, the formalities of takeover of the unit from Lakme Limited have been completed and effective from 23rd July, 1997 the unit has become a division of Bal Pharma Limited. The companys product range has been expanded with the introduction of AZIWIN, CAFIMOL CORTIDERM.The company has added further product range Zanovid, Aziwin, Dry Syrup, Meloxi, Ocium M, Progit MPS in its ethical division during 19992000. As part of the expansion of the product range, the company has introduced Cardiac Specialities Products. To market these products, a new division named SERVETUS has started functioning during 2001. New products like Amiloride,Benzydamine and Ebastine were rolled into the market during 2002. The commercial production of Formulation Plant in Uttarakhand started from 1st January, 2009. The Company floated Lifezen Healthcare Pvt Ltd during the year 201415 as its subsidiary. It ventured into heath care sector through its subsidiary i.e. Balance Clinics LLP. In 201617, it commenced its project on construction of an fully integrated API unit with an annual production capacity of 270 metric tonnes of assorted API products including Gliclazide, Ebastine, Amiloride HCL, Benzydamine HCL, Pregablin etc, located at Gauribidanur near Bangalore with an estimated investment of Rs 45 Crores. In 201718, the Company acquired 100% stake and management control of Golden Drugs Private Ltd, an Udaipur, Rajasthan involved in the manufacture of bulk drugs and intermediates costing Rs 14 Crores. It earmarked Rs. 36 Cr. for setting up of an bulk drugsmanufacturing unit at Yadgir District , Karnataka in year 202223. It launched Sitagliptin (a DPP4 Inhibitor) in the plain form, and as a combination with Metformin under the brand names SITABEND SITABENDM, respectively in 2023.

    As of 01 Jul, 2025, Bal Pharma share price is ₹101.2. The stock opened at ₹103 and had closed at ₹101.5 the previous day. During today’s trading session, Bal Pharma share price moved between ₹101.13 and ₹103.29, with an average price for the day of ₹102.21. Over the last 52 weeks, the stock has recorded a low of ₹78.06 and a high of ₹157.98. In terms of performance, Bal Pharma share price has declined by 17.5% over the past six months and has declined by 16.33% over the last year.

    Read More
    Bal Pharma SIP Return Calculator

    Over the past

    1 year
    3 years
    5 years

    Total Investment of ₹65,00,000

    Would have become ₹59,94,988 (-7.77%)

    Daily SIP of 25,000 would have become 59,94,988 in 1 year with a gain of -5,05,011 (-7.77%)

    View details of Market Depth

    Bal Pharma Fundamental

    Market Cap (in crs)

    161.60

    Face Value

    10

    Turnover (in lacs)

    4.88

    Key Metrics

    Qtr Change %
    35.96% Fall from 52W High
    20.6
    Dividend yield 1yr %
    High in industry
    1.2

    Bal Pharma Key Financials

    View more

    *All values are in ₹ Cr.

    *All values are in ₹ Cr.

    *All values are in ₹ Cr.

    *All values are in ₹ Cr.

    Bal Pharma Quarterly Revenue
    Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
    81.88 Cr
    73.15 Cr
    73.69 Cr
    74.36 Cr
    94.63 Cr
    Bal Pharma Yearly Revenue
    Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
    305.29 Cr
    342.07 Cr
    305.16 Cr
    286.37 Cr
    251.67 Cr
    172.93 Cr
    Bal Pharma Quarterly Net Profit/Loss
    Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
    5.42 Cr
    0.52 Cr
    1.04 Cr
    0.26 Cr
    5.53 Cr
    Bal Pharma Yearly Net Profit/Loss
    Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
    7.24 Cr
    7.45 Cr
    2.62 Cr
    5.7 Cr
    4.71 Cr
    -12.89 Cr

    Bal Pharma Result Highlights

    • Bal Pharma Ltd reported a 31.8% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Mar (Q4FY25). On a year-on-year (YoY) basis, it witnessed a growth of 17.5%.

    • Its expenses for the quarter were up by 24.9% QoQ and 13.8% YoY.

    • The net profit increased 963.5% QoQ and increased 241.4% YoY.

    • The earnings per share (EPS) of Bal Pharma Ltd stood at 3.7 during Q4FY25.

      Read more

    Data Source: BSE, Company announcements

    The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.

    Top Mutual Fund Invested in Bal Pharma

    Promoter
    50.9%
    Foreign Institutions
    0.1%
    Public
    49%
    Promoter
    50.9%
    Foreign Institutions
    0.1%
    Public
    49%
    Promoter
    50.9%
    Foreign Institutions
    0.1%
    Public
    49%
    Promoter
    51.2%
    Foreign Institutions
    0.1%
    Public
    48.6%
    Promoter
    51.2%
    Foreign Institutions
    0.1%
    Public
    48.6%
    Promoter
    51.2%
    Foreign Institutions
    0.1%
    Public
    48.6%

    Bal Pharma Technical Analysis

    Moving Averages Analysis
    101.68
    Current Price
    Bullish Moving Averages
    12
    Bearish Moving Averages
    4
    5Day EMA
    100.40
    10Day EMA
    100.40
    12Day EMA
    100.40
    20Day EMA
    100.40
    26Day EMA
    100.30
    50Day EMA
    100.20
    100Day EMA
    102.20
    200Day EMA
    106.20
    5Day SMA
    100.00
    10Day SMA
    99.80
    20Day SMA
    100.80
    30Day SMA
    100.00
    50Day SMA
    100.60
    100Day SMA
    98.30
    150Day SMA
    105.70
    200Day SMA
    111.30
    Delivery & Volume

    Delivery & Volume

    PeriodCombined Delivery VolumeNSE+BSE Traded Volume
    Day Rs
    10637 Rs
    19622 Rs
    Week Rs
    11624 Rs
    20249 Rs
    Month Rs
    18184 Rs
    32228 Rs
    102.00
    Pivot
    Resistance
    First Resistance
    103.15
    Second Resistance
    104.79
    Third Resistance
    105.94
    Support
    First Support
    100.36
    Second support
    99.21
    Third Support
    97.57
    Relative Strength Index
    53.56
    Money Flow Index
    75.93
    MACD
    0.06
    MACD Signal
    0.17
    Average True Range
    3.68
    Average Directional Index
    13.92
    Rate of Change (21)
    4.38
    Rate of Change (125)
    -16.91

    Bal Pharma Latest News

    30 JUN 2025 | Monday

    Bal Pharma Ltd - 524824 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

    20 JUN 2025 | Friday

    Bal Pharma Ltd - 524824 - Closure of Trading Window

    16 JUN 2025 | Monday

    Bal Pharma Ltd - 524824 - Intimation To The Physical Shareholders For Updating KYC.

    View More

    Bal Pharma Share Price FAQs

    Bal Pharma share price is ₹101.68 in NSE and ₹100.95 in BSE as on 1/7/2025.

    Bal Pharma share price in the past 1-year return was -15.29. The Bal Pharma share hit a 1-year low of Rs. 78.06 and a 1-year high of Rs. 157.98.

    The market cap of Bal Pharma is Rs. 161.6 Cr. as of 1/7/2025.

    The PE ratios of Bal Pharma is 20.72 as of 1/7/2025.

    The PB ratios of Bal Pharma is 1.43 as of 1/7/2025

    You can easily buy Bal Pharma shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

    The 52-week high and low of Bal Pharma share price is ₹157.98 and ₹78.06 as of 1/7/2025.

    Please be aware that Bal Pharma stock prices are subject to continuous fluctuations due to various factors.

    Popular Stocks
    817.30
    -3.05 (-0.37%)
    1,523.90
    +23.30 (+1.55%)
    2,011.10
    +9.60 (+0.48%)
    1,604.50
    +2.70 (+0.17%)
    3,439.00
    -23.00 (-0.66%)
    Top Gainers
    7,471.00
    +229.00 (+3.16%)
    432.30
    +10.80 (+2.56%)
    1,527.80
    +27.20 (+1.81%)
    330.85
    +4.10 (+1.25%)
    882.90
    +10.80 (+1.24%)
    Top Losers
    1,173.00
    -26.20 (-2.18%)
    2,426.00
    -39.30 (-1.59%)
    260.80
    -3.35 (-1.27%)
    699.30
    -7.55 (-1.07%)
    6,155.50
    -62.00 (-1.00%)
    Open Demat Account
    +91 -

    Open Demat Account
    +91 -